DrugDashboards

Olanzapine

Olanzapine · OLANZAPINE 20 mg/1 · Tablet · Oral · Modavar Pharmaceuticals LLC

NDC 72241-0056-04 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

9 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 61269-0635-30) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of sale
$51.09per unit
middle half $51.08$51.10 · 2 plans · Apr 1, 2026
Est. net of rebates
≈ $51.09
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
0%of plans cover it
tier 1 · prior auth 100% · step therapy 0% · qty limit 100%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 6 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for olanzapine (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $31.43 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Zyprexa Relprevv

Regulatory

Application
ANDA210022
TE code
AB
Approval date
Feb 24, 2023
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olanzapine (Tablet)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedOLANZAPINE 10 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedOLANZAPINE 20 mg/1Jul 15, 2026Sep 3, 2026
Ascend Laboratories, LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Ascend Laboratories, LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
Cadila Pharmaceuticals LimitedOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
H2-Pharma LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
HEC Pharm USA Inc.OLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 10 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 15 mg/1Jul 15, 2026Sep 2, 2026
Modavar Pharmaceuticals LLCOLANZAPINE 5 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedOLANZAPINE 20 mg/1Jul 15, 2026Sep 2, 2026
Torrent Pharmaceuticals LimitedOLANZAPINE 7.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olanzapine — NDC 72241-0056-04," retrieved September 3, 2026, https://drugdashboards.com/drug/72241005604.

Free to cite with attribution — see how the data is put together.